Open Orphan tip of the year update on mega contract win
by Tom Winnifrith Open Orphan (ORPH) was one of my tips of the year at a 4.6p offer. The shares are now 5.5p bid – the recent market sell off hitting it like nearly all other stocks. But the news today of a contract potentially worth £10 million plus really does slam home the message […]
Irish Times – Open Orphan seals deal that could net more than €11.6m
by Colin Gleeson Dublin-listed pharma group announces contract with European biotech company Dublin-listed pharma services company Open Orphan has announced the signing of a new contract with a European biotech company that could yield it more than £10 million in revenue this year. Open Orphan, a European-focussed, rare and orphan drug consulting services platform, informed the Irish […]
Open Orphan #ORPH – New hVIVO contract signed with a European Biotech Company to provide RSV human challenge study
6 March 2020: Open Orphan plc (ORPH) the rapidly growing CRO specialist pharmaceutical services Group which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce the signing of a new contract with a European Biotech Company for the provision of a RSV human […]
Alan Green talks Coronavirus and markets, plus Open Orphan #ORPH & Metro Bank #MTRO on the UK Investor Magazine podcast
Alan Green discusses Coronavirus and markets, plus Open Orphan #ORPH & Metro Bank #MTRO with Jonathan Roy on the UK Investor Magazine podcast. Link on the image to listen.
Shares Magazine Spotlight – Open Orphan lining up for coronavirus fight
Open Orphan #ORPH – Appointment of new Director
Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services , is pleased to announce, further to its announcement of 13 February 2020, the appointment to the board of Leo Toole as Chief Financial […]
Open Orphan #ORPH – Result of Rule 15 Offer and Total Voting Rights
Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs , announces, further to its announcement of 7 January 2020, the results of the Rule 15 Offer previously issued to the holders of options in hVIVO. Under the Rule 15 offer (the “Rule 15 Offer”), 4 hVIVO option holders […]
Built to sell – can dealmaker Cathal Friel build (and sell) a £80m company in two years?
by Sean Keyes | Financial Correspondant Serial dealmaker Cathal Friel has an audacious plan: build and sell a pharma services company in two years. It could fetch as much as £100 million. What exactly is his plan? And will it work? On the cover of the fifth edition of Dr John Oxford’s book Human Virology […]
Open Orphan #ORPH presents at ShareSoc Growth Company Seminar, Manchester
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce that the Company will […]
Open Orphan #ORPH – Appointment of Group Chief Financial Officer
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce the appointment […]